DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aciphex (Rabeprazole Sodium) - Current Clinical Trials

 
 



Aciphex Related Clinical Trials

Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding [Recruiting]

Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers [Terminated]

E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers [Completed]

A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injury [Active, not recruiting]

E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers [Completed]

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection [Completed]

A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers [Completed]

A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers [Completed]

A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) [Completed]

Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI [Completed]

A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive [Completed]

A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810) [Completed]

Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) [Completed]

Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex� Tablets 20 mg [Completed]

A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection [Completed]

Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex� Tablets 20 mg [Completed]

A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult Volunteers [Completed]

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex� Delayed-Release Tablets 20 mg [Completed]

Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD [Withdrawn]

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors [Recruiting]

A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients [Completed]

Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel [Completed]

An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis [Completed]

Effects of YF476 and Rabeprazole on Gastric Function [Completed]

A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations [Recruiting]

Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori [Terminated]

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults [Completed]

Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections [Recruiting]

A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets [Completed]

A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204) [Completed]

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD) [Completed]

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) [Completed]

Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) [Completed]

Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of TAK-438 [Completed]

Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD) [Completed]

A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn [Completed]

Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) [Completed]

Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) [Completed]

Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. [Completed]

Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets [Recruiting]

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [Recruiting]

Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD) [Completed]

A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants [Not yet recruiting]

Maintenance Intermittent Therapy for Symptomatic GERD Patients [Completed]

Rabeprazole Protection of Aspirin Induced Gastric Damage. [Completed]

A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes [Completed]

Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period [Completed]

Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. [Completed]

A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) [Completed]

A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms [Completed]

Safety of Rabeprazole in Patients Under Multiple Treatments [Terminated]

A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD) [Completed]

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects [Recruiting]

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer [Recruiting]

A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg [Completed]

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions [Completed]

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fasted Conditions [Completed]

Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) [Completed]

A Study to Evaluate the Effect of a Proton-Pump Inhibitor (Rabeprazole) on the Relative Bioavailability of GDC 0973 in Healthy Subjects [Completed]

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin [Recruiting]

Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects [Completed]

A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib [Completed]

Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole [Completed]

Study of E3810 for Healthy Japanese Male (Under Fasting Condition) [Completed]

A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition) [Completed]

Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients [Completed]

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection [Recruiting]

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection [Recruiting]

A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole [Completed]

Concomitant Therapy of H. Pylori [Recruiting]

A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive [Completed]

Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991) [Completed]

A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet [Completed]

Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors [Active, not recruiting]

A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease [Completed]

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole [Completed]

Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food [Completed]

Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD [Completed]

H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk [Recruiting]

Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. [Completed]

Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin [Completed]

Sleep Disorders and Gastroesophageal Reflux Disease (GERD) [Completed]

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori [Active, not recruiting]

Effects of Gastric pH on the Pharmacokinetics of Dasatinib [Completed]

CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing [Completed]

Effect of Inhibitors of the Proton Pump on Intestinal Transporters and Their Impact on the Pharmacokinetics of Dabigatran - Mechanistic and Clinical Approach -BIPP Study [Active, not recruiting]

Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers [Completed]

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Completed]

Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Completed]

Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment [Completed]

Effects of Gastric pH on the Pharmacokinetics of Atazanavir [Completed]

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium [Completed]

To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole [Completed]

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017